Dihydroergotamine MesylateMeSH concept

http://www.has-sante.fr/portail/display.jsp?id=c_574629
http://www.has-sante.fr/portail/jcms/c_1256031/tamik
http://www.has-sante.fr/portail/upload/docs/application/pdf/2012-06/tamik_230520128avis_ct12044.pdf
2012
France
French
antimigraine preparations
administration, oral
capsules
analgesics, non-narcotic
dihydroergotamine
vasoconstrictor agents
migraine disorders
dihydroergotamine
treatment outcome
Dihydroergotamine Mesylate
randomized controlled trials as topic
fibrosis
risk assessment
product surveillance, postmarketing
dihydroergotamine
Dihydroergotamine Mesylate
vasoconstrictor agents
analgesics, non-narcotic
evaluation of the transparency committee

---
http://www.has-sante.fr/portail/upload/docs/application/pdf/2012-06/dhe_amdipharm_23052012_avis_ct12061.pdf
http://www.has-sante.fr/portail/jcms/c_1256037/dihydroergotamine-amdipharm
2012
France
French
evaluation of the transparency committee
antimigraine preparations
dihydroergotamine
dihydroergotamine
administration, oral
injections
insurance, health, reimbursement
treatment outcome
Dihydroergotamine Mesylate
Dihydroergotamine Mesylate
dihydroergotamine
analgesics, non-narcotic
analgesics, non-narcotic
vasoconstrictor agents
vasoconstrictor agents
migraine disorders
randomized controlled trials as topic
fibrosis
risk assessment
product surveillance, postmarketing

---
http://www.has-sante.fr/portail/jcms/c_1256030/seglor
http://www.has-sante.fr/portail/upload/docs/application/pdf/2012-06/seglor_23052012_avis_ct11066_12147.pdf
2012
France
French
evaluation of the transparency committee
antimigraine preparations
dihydroergotamine
administration, oral
treatment outcome
insurance, health, reimbursement
dihydroergotamine
Dihydroergotamine Mesylate
Dihydroergotamine Mesylate
analgesics, non-narcotic
analgesics, non-narcotic
migraine disorders
vasoconstrictor agents
vasoconstrictor agents
randomized controlled trials as topic
fibrosis
risk assessment
product surveillance, postmarketing
dihydroergotamine

---
http://www.has-sante.fr/portail/upload/docs/application/pdf/2012-06/ikaran_23052012_avis_ct12075_11038.pdf
http://www.has-sante.fr/portail/jcms/c_574461/ikaran
http://www.has-sante.fr/portail/jcms/c_1256023/ikaran
2012
France
French
evaluation of the transparency committee
antimigraine preparations
dihydroergotamine
Dihydroergotamine Mesylate
Dihydroergotamine Mesylate
dihydroergotamine
dihydroergotamine
administration, oral
insurance, health, reimbursement
treatment outcome
migraine disorders
analgesics, non-narcotic
analgesics, non-narcotic
randomized controlled trials as topic
vasoconstrictor agents
vasoconstrictor agents
risk assessment
fibrosis
product surveillance, postmarketing

---
http://www.has-sante.fr/portail/jcms/c_1294640/dihydroergotamine-amdipharm-ikaran-lp-seglor-seglor-lyoc-tamik-dihydroergotamine-et-desernil-methysergide-derives-ergotes
http://www.has-sante.fr/portail/jcms/c_1294612/dhe-migraine-synthese-23052012
http://www.has-sante.fr/portail/jcms/c_1257411/dhe-amdipharm-23052012-avis-ct12061
http://www.has-sante.fr/portail/jcms/c_1257431/ikaran-23052012-avis-ct12075-11038
http://www.has-sante.fr/portail/jcms/c_1257339/seglor-23052012-avis-ct11066-12147
http://www.has-sante.fr/portail/jcms/c_1257452/tamik-23052012-avis-ct12044
http://www.has-sante.fr/portail/jcms/c_1257408/desernil-23052012-avis-ct12062-11053
2012
France
French
antimigraine preparations
migraine disorders
treatment outcome
insurance, health, reimbursement
administration, oral
methysergide
methysergide
Methysergide Maleate
injections
dihydroergotamine
Dihydroergotamine Mesylate
dihydroergotamine
Delayed-Action preparations
dihydroergotamine
Dihydroergotamine Mesylate
methysergide
Methysergide Maleate
guidelines for drug use
evaluation of the transparency committee

---
http://www.has-sante.fr/portail/jcms/c_968485/dihydroergotamine-amdipharm-diergospray
http://www.has-sante.fr/portail/upload/docs/application/pdf/2010-07/dihydroergotamine_amdipharm_-_ct-7113.pdf
2010
France
French
antimigraine preparations
administration, intranasal
dihydroergotamine
dihydroergotamine
insurance, health, reimbursement
migraine disorders
treatment outcome
venous insufficiency
hypotension, orthostatic
injections
administration, oral
nasal sprays
Dihydroergotamine Mesylate
evaluation of the transparency committee

---
http://www.lecrat.eu/?s=Dihydroergotamine
2009
France
French
pregnancy
dihydroergotamine
vasoconstrictor agents
analgesics, non-narcotic
dihydroergotamine
Dihydroergotamine Mesylate
drug information

---
http://www.has-sante.fr/portail/display.jsp?id=c_538327
http://www.has-sante.fr/portail/upload/docs/application/pdf/ct-3954_seglor_.pdf
2007
France
French
antimigraine preparations
analgesics, non-narcotic
administration, oral
dihydroergotamine
vasoconstrictor agents
migraine disorders
hypotension, orthostatic
dihydroergotamine
insurance, health, reimbursement
Dihydroergotamine Mesylate
evaluation of the transparency committee

---
http://www.has-sante.fr/portail/upload/docs/application/pdf/ct-3027_ikaran_.pdf
http://www.has-sante.fr/portail/display.jsp?id=c_493289
2007
France
French
antimigraine preparations
pharmaceutical solutions
tablets
dihydroergotamine
vasoconstrictor agents
migraine disorders
analgesics, non-narcotic
hypotension, orthostatic
dihydroergotamine
venous insufficiency
insurance, health, reimbursement
Delayed-Action preparations
Dihydroergotamine Mesylate
evaluation of the transparency committee

---